|Last Price$57.78||Day Change (%)0.56%|
|Open Price$57.68||Day Change ($)0.32|
|Day Range57.59–58.02||52-Week Range49.30–62.20|
As of Fri 12/26/2014 05:03 PM EST | USD
Brent Saunders faces challenge of running combined Actavis-Allergan
The sale to Bayer monetizes Merck's consumer unit at a strong valuation, and removes Merck from an area where it lacks scale.
American's managers have been busy buying unloved large caps.
With a rock-solid belief in their strategy, the managers of Homestead Value confidently go about their business.
Two veteran investors discuss the winners and losers of reform and where they're looking for future growth.
Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.